共 49 条
- [1] Sobel J.D., Faro S., Force R., Et al., Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations, Am. J. Obstet. Gynecol., 178, pp. 203-211, (1998)
- [2] Calderone R.A., Candida and Candidiasis, (2002)
- [3] Sobel J.D., Pathogenesis and treatment of recurrent vulvovaginal candidiasis, Clin. Infect. Dis., 14, (1992)
- [4] Romani L., Puccetti P., Bistoni F., Biological role of Th cell subsets in candidiasis, Th1 and Th2 Cells in Health and Disease, pp. 114-137, (1996)
- [5] Clift R.A., Candidiasis in the transplant patient, Am. J. Med., 77, SUPPL. 4D, pp. 34-38, (1984)
- [6] Samaranayake L.P., Oral mycoses in HIV infection, Oral Surg. Oral Med. Oral Pathol., 73, pp. 171-180, (1992)
- [7] Mathews H.L., Witek-Janusek L., Host defense against oral, esophageal, and gastrointestinal candidiasis, Candida and Candidiasis, pp. 179-192, (2002)
- [8] Fidel Jr. P.L., Sobel J.D., Immunopathogenesis of recurrent vulvovaginal candidiasis, Clin. Micro. Rev., 9, pp. 335-348, (1996)
- [9] Fidel Jr. P.L., Lynch M.E., Redondo-Lopez V., Et al., Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis (RVVC), J. Infect. Dis., 168, pp. 1458-1465, (1993)
- [10] Nawrot U., Grzybek-Hryncewicz K., Zielska U., Et al., The study of cell-mediated immune response in recurrent vulvovaginal candidiasis, FEMS Immunol. Med. Microbiol., 29, pp. 89-94, (2000)